Abstract
Thromboembolisms occur as a consequence of genetic predispositions, underlying disorders, and direct triggers such as dehydration, infection, or injury. Heritable defects in the coagulant and anticoagulant pathways result in the development of venous thromboembolism (VTE) with or without apparent triggers. The genetic risks of VTE include the deficiency of anticoagulant factors of protein C (PC), protein S (PS), and antithrombin, as well as the variants of coagulation factors of factor V G1691A (factor V Leiden) and prothrombin (factor II) G20210A. Hereditary anticoagulant deficiencies are suspected in young adult VTE, neonatal purpura fulminans, patients having recurrent VTE, and/or family history of thrombosis or anticoagulant deficiencies. The hereditary anticoagulant deficiencies are difficult to diagnose in infants and young children without the genetic tests, because these activities are physiologically lower in childhood than in adulthood. Unexplained dissociation among PC, PS, and factor VII activity levels may portend a diagnosis of heritable PC or PS deficiency. The coagulation studies by using the age-dependent standards have then high sensitivity in screening for anticoagulant deficiencies. Nevertheless, repeated sampling, family studies, and genetic analyses along with the detailed information of reported cases are essential for the diagnosis for anticoagulant deficiency.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- APC:
-
Activated protein C
- APTT:
-
Activated partial thromboplastin time
- AT:
-
Antithrombin
- CT:
-
Computed tomography
- DIC:
-
Disseminated intravascular coagulation
- DVT:
-
Deep venous thrombosis
- OR:
-
Odds ratio
- PC:
-
Protein C
- PIVKAII:
-
Vitamin K absence or antagonists II
- PS:
-
Protein S
- PT:
-
Prothrombin time
- rr:
-
Reference range
- VTE:
-
Venous thromboembolism
References
Alhenc-Gelas M, Plu-Bureau G, Horellou MH et al (2016) GEHT genetic thrombophilia group. PROS1 genotype phenotype relationships in a large cohort of adults with suspicion of inherited quantitative protein S deficiency. Thromb Haemost 115:570–579
Bertina RM, Koeleman BP, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369(6475):64–67
Caspers M, Pavlova A, Driesen J et al (2012) Deficiencies of antithrombin, protein C and protein S – practical experience in genetic analysis of a large patient cohort. Thromb Haemost 108:247–257
Dahlback B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to previously unrecognized mechanism characterized by poor anti-coagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 90:1004–1008
Griffin JH, Zlokovic BV, Mosnier LO (2015) Activated protein C: biased for translation. Blood 125:2898–2907
Holzhauer S, Goldenberg NA, Junker R et al (2012) Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study. Blood 120:1510–1515
Ichiyama M, Ohga S, Ochiai M et al (2016) Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism. Pediatr Res 79:81–86
Ikejiri M, Wada H, Sakamoto Y et al (2010) The association of protein S Tokushima-K196E with a risk of deep vein thrombosis. Int J Hematol 92:302–305
Kenet G, Liitkhoff LK, Albisetti M et al (2010) Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 121:1838–1847
Middeldorp S, Meinardi JR, Koopman MM et al (2001) A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med 135:322–327
Ohga S, Ishiguro A, Takahashi Y et al (2013a) Protein C deficiency as the major cause of thrombophilias in childhood. Pediatr Int 55:267–271
Ohga S, Kang D, Kinjo T et al (2013b) Paediatric presentation and outcome of congenital protein C deficiency in Japan. Haemophilia 19:378–384
Quinn LM, Drakeford C, O’Donnell JS et al (2015) Engineering activated protein C to maximize therapeutic efficacy. Biochem Soc Trans 43:691–695
Ranieri VM, Thompson BT, Barie PS et al (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064
Soria JM, Almasy L, Souto JC et al (2000) Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood 95:2780–2795
Tait RC, Walker ID, Reitsma PH et al (1995) Prevalence of protein C deficiency in the healthy population. Thromb Haemost 73:87–93
Takahashi Y, Yoshioka A (1994) Hemostasis and its regulation system in childhood. Jpn J Pediatr Hematol 8:389–397 in Japanese
Umemura Y, Yamakawa K, Ogura H et al (2016) Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost 14:518–530
Yin T, Miyata T (2014) Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians. J Thromb Thrombolysis 37:56–65
Young G, Albisetti M, Bonduel M et al (2008) Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 118:1373–1382
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ishimura, M., Ohga, S. (2019). Hereditary Anticoagulant Deficiencies. In: Oohashi, T., Tsukahara, H., Ramirez, F., Barber, C., Otsuka, F. (eds) Human Pathobiochemistry. Springer, Singapore. https://doi.org/10.1007/978-981-13-2977-7_17
Download citation
DOI: https://doi.org/10.1007/978-981-13-2977-7_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2976-0
Online ISBN: 978-981-13-2977-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)